Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$38.2B
Enterprise value$46.9B
Revenue$2.4B +5.1%
ROIC6.7%
EPS, diluted$1.78 −6.8%
Modern Valuation (EOD)
Market Cap$38.2B
Enterprise Value$46.9B
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT30.10
EV / Sales19.74
P / E (GAAP)49.58
P / FCF—
P / Oper. CF15.35
P / Book3.93
Owner & Cash Yields
True FCF Yield—
FCF Yield—
Owner Earn. Yield—
Earnings Yield2.0%
Shareholder Yield+2.5%
Buyback Yield3.2%
Dividend Yield1.23%
Dividend / sh$0.84
Payout Ratio—
FCF / sh—
EPS (diluted)$1.78
Compounder & Returns
Rule of 40—
ROIC6.7%
Cash ROIC (CROIC)—
GP / Assets—
ROE7.9%
ROA3.9%
Gross Margin—
Oper. Margin65.6%
Net Margin32.4%
FCF Margin—
True FCF Margin—
Quality & Dilution
Cash Conversion—
Accrual Ratio−8.8%
SBC % of FCF—
SBC % of Rev12.2%
Reinvest. Rate18%
Sales Growth Y/Y+5.1%
Sales 3Y CAGR+2.1%
EPS Growth Y/Y−6.8%
FCF Growth Y/Y—
FCF 3Y CAGR—
Share Change Y/Y−5.0%
Balance Sheet & Scale
Revenue (FY)$2.4B
Gross Profit (FY)—
Oper. Income (FY)$1.6B
GAAP Net Income$770.9M
True FCF (ex-SBC)—
Cash & Equiv$618.7M
Total Debt$9.3B
Net Cash (Debt)$-8.7B
Net Cash % MCap−22.8%
Debt / FCF (yrs)—
Current Ratio2.40388.13M sh
Price & Technicals (EOD)
Perf Week−1.24%
Perf Month+7.37%
Perf Quarter+11.61%
Perf Half Y+25.60%
Perf YTD+34.96%
SMA 20 Dist+1.27%$67.59
SMA 50 Dist+9.86%$62.31
SMA 100 Dist+12.66%$60.76
Window High−2.23%$70.01
Window Low+36.35%$50.20
RSI (14) · Vol63.318%v
Income Distribution & Cash Flow ConversionHow every dollar of RPRX revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$2.3B
$2.2B
$2.4B
$2.3B
$2.4B
+5.1%
+1.0%
Research & Development (R&D)
$200.1M
$177.1M
$52.0M
$2.0M
$452.0M
+22500.0%
+22.6%
Operating Income (EBIT) ▸
$1.4B
$307.1M
$1.5B
$1.3B
$1.6B
+20.7%
+2.2%
Interest Expense
$166.1M
$188.0M
$187.2M
$225.5M
$307.7M
+36.4%
+16.7%
Income Tax Expense
$0
$0
$0
$0
$0
—
—
GAAP Net Income ▸
$619.7M
$42.8M
$1.1B
$859.0M
$770.9M
−10.2%
+5.6%
Diluted EPS ▸
$1.49
$0.10
$2.53
$1.91
$1.78
−6.8%
+4.5%
Diluted Shares
414.8M
438.0M
602.9M
594.1M
564.5M
−5.0%
+8.0%
Balance Sheet
Cash & Equivalents
$1.5B
$1.7B
$477.0M
$929.0M
$618.7M
−33.4%
−20.4%
Total Current Assets
$2.9B
$2.6B
$1.3B
$1.8B
$1.5B
−15.2%
−14.6%
Total Assets
$17.5B
$16.8B
$16.4B
$18.2B
$19.6B
+7.7%
+2.9%
Total Current Liabilities
$171.3M
$1.2B
$161.4M
$1.3B
$636.2M
−49.2%
+38.8%
Total Debt (Short + Long Term)
$7.1B
$8.1B
$6.1B
$8.6B
$9.3B
+8.4%
+7.1%
Total Liabilities
$7.3B
$7.3B
$6.3B
$7.9B
$9.9B
+25.7%
+8.1%
Stockholders' Equity
$10.2B
$9.5B
$10.1B
$10.3B
$9.7B
−6.1%
−1.3%
Net Cash / (Net Debt)
$-5.6B
$-6.4B
$-5.7B
$-7.7B
$-8.7B
−13.4%
—
Invested Capital
$15.8B
$15.9B
$15.7B
$18.0B
$18.4B
+2.2%
+3.9%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$2.0B
$2.1B
$3.0B
$2.8B
$2.5B
−10.1%
+5.4%
Depreciation & Amortization (D&A)
—
—
$0
$0
$3.9M
—
—
Stock-Based Compensation (SBC)
$2.4M
$2.2M
$2.4M
$2.3M
$289.9M
+12267.5%
+230.0%
Share Repurchases (Buybacks)
$0
$0
$304.8M
$229.7M
$1.2B
+434.5%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
13 big days in a year, and what we hold on each
A big day is a close more than 2.83% from the one before, three times RPRX’s median day (0.94%). On 10 of the 13, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±2.83%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayRPRXWhat we hold that dayGroup (median of 4) · each
1 Mar 5, 2026−3.69%
Before our storiesgroup −2.2%, moved with RPRX
1Mar 5, 2026−3.69%
Before our stories
−2.2% moved with RPRXMRK −3.5 · JNJ −2.3 · LLY −2.0 · ABBV −1.6
2 Mar 25, 2026+3.20%
Before our storiesgroup +1.7%, moved with RPRX
2Mar 25, 2026+3.20%
Before our stories
+1.7% moved with RPRXMRK +2.6 · JNJ +2.0 · LLY +1.5 · ABBV +1.0
3 Mar 31, 2026+3.45%
Before our storiesgroup +1.9%, moved with RPRX
3Mar 31, 2026+3.45%
Before our stories
+1.9% moved with RPRXLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
4 Apr 17, 2026+3.14%
Before our storiesgroup +1.2%, did not move with it
4Apr 17, 2026+3.14%
Before our stories
+1.2% did not move with itMRK +3.1 · LLY +2.5 · JNJ −0.1 · ABBV −0.3
5 May 13, 2026+3.00%
Before our storiesgroup +1.8%, moved with RPRX
5May 13, 2026+3.00%
Before our stories
+1.8% moved with RPRXJNJ +2.8 · LLY +2.6 · MRK +1.0 · ABBV +0.3
6 Jun 23, 2026+3.32%
Nothing on RPRXgroup +2.7%, moved with RPRX
6Jun 23, 2026+3.32%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+2.7% moved with RPRXMRK +3.6 · JNJ +3.4 · ABBV +2.1 · LLY +0.5
7 Jul 2, 2026+3.57%
Nothing on RPRXgroup +3.5%, moved with RPRX
7Jul 2, 2026+3.57%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+3.5% moved with RPRXABBV +4.0 · JNJ +3.6 · MRK +3.3 · LLY +1.9
8 Jul 16, 2026+3.94%
Nothing on RPRXgroup +2.2%, moved with RPRX
8Jul 16, 2026+3.94%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+2.2% moved with RPRXABBV +4.2 · MRK +3.3 · JNJ +1.2 · LLY +1.1
9 Aug 19, 2026+3.42%
Nothing on RPRXgroup +3.6%, moved with RPRX
9Aug 19, 2026+3.42%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+3.6% moved with RPRXMRK +12.6 · LLY +4.5 · ABBV +2.7 · JNJ +0.8
−2.2% did not move with itABBV −3.0 · JNJ −2.2 · LLY −2.2 · MRK −1.2
11 Sep 10, 2026−3.04%
Nothing on RPRXgroup −0.2%, did not move with it
11Sep 10, 2026−3.04%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
−0.2% did not move with itMRK −1.9 · JNJ −0.3 · LLY −0.1 · ABBV +1.6
12 Oct 14, 2026+4.28%
Nothing on RPRXgroup +3.5%, moved with RPRX
12Oct 14, 2026+4.28%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+3.5% moved with RPRXMRK +3.8 · LLY +3.6 · ABBV +3.3 · JNJ +2.1
13 Oct 20, 2026+3.29%
Nothing on RPRXgroup +2.8%, moved with RPRX
13Oct 20, 2026+3.29%
Nothing on RPRXNo RPRX story, brief or results filing in our record that day
+2.8% moved with RPRXLLY +3.5 · MRK +3.3 · ABBV +2.3 · JNJ +2.2
A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in RPRX’s SEC industry; “moved with RPRX” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). RPRX reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.
Reported Feb 11, 2026
day 1+0.09%day 6+2.04%
Reported May 6, 2026
day 1+0.56%day 6+5.57%
Reported Aug 5, 2026
day 1+0.47%day 6+3.03%
Reported Nov 4, 2026
day 1+1.75%day 6+5.44%
Next report: expected early-to-mid FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 4 report: +3.09%. Four reports is a small sample.
Each line is RPRX’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
RPRX against four drug peers, a year at 100
RPRX is up 75.9% in a year. All four did less: Merck (+36.8%), Johnson & Johnson (+32.7%), Eli Lilly (+27.1%) and AbbVie (+21.1%). Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in RPRX’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.